✦ LIBER ✦

Does Rasagiline Have a Disease-Modifying Effect on Parkinson’s Disease?

✍ Scribed by Shyamal H. Mehta; John C. Morgan; Kapil D. Sethi

Book ID: 107545780
Publisher: Springer
Year: 2010
Tongue: English
Weight: 89 KB
Volume: 10
Category: Article
ISSN: 1528-4042
DOI: 10.1007/s11910-010-0133-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What does apoptosis have to do with Park

What does apoptosis have to do with Parkinson's disease?

✍ Dr. Richard B. Banati; Dr. Stavia Blunt; Dr. Manuel B. Graeber 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB

Neuroprotection by Rasagiline: A New The

Neuroprotection by Rasagiline: A New Therapeutic Approach to Parkinson's Disease?

✍ Fabio Blandini 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Maternal effect on Parkinson's disease

✍ Raúl De La Fuente-Fernández 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 3 views

Parkinson’s disease I: glucocerebrosidas

Parkinson’s disease I: glucocerebrosidase mutations, family history of melanoma and questionable effects of rasagiline

✍ Michael Strupp 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 125 KB

Does fluoxetine aggravate Parkinson's di

Does fluoxetine aggravate Parkinson's disease? A pilot prospective study

✍ Jean-Louis Montastruc; Nelly Fabre; Olivier Blin; Jean-Michel Senard; Olivier Ra 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 1 views

Effects of tyramine administration in Pa

Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline

✍ J. Antonelle deMarcaida; Steven R. Schwid; William B. White; Karen Blindauer; St 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

## Abstract Rasagiline is a novel, potent, and selective MAO‐B inhibitor shown to be effective for Parkinson's disease. Traditional nonselective MAO inhibitors have been associated with dietary tyramine interactions that can induce hypertensive reactions. To test safety, tyramine challenges (50–75